Market Overview:
The global papaverine hydrochloride injection market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cardiovascular diseases, rising geriatric population, and growing demand for minimally invasive surgeries. By type, the 30 mg/mL segment is expected to account for the largest share of the global papaverine hydrochloride injection market in 2018. By application, hospital pharmacies are expected to account for the largest share of the global papaverine hydrochloride injection market in 2018.
Product Definition:
A potent smooth muscle relaxant used to relieve pain and improve blood flow, papaverine hydrochloride injection is also effective in treating erectile dysfunction. It is a vasodilator that works by relaxing the smooth muscles in the body, which increases blood flow.
30 mg/mL:
30 mg/mL is the concentration of papaverine hydrochloride used for therapeutic purposes. It’s a colorless, water-soluble, and highly soluble in alcohol form of dihydroergotamine mesylate. The drug is widely prescribed to treat severe chronic pain due to diabetic neuropathy or other causes that are not responding to other medications such as non-narcotic analgesics or opioids.
120 mg/10 mL:
120 mg/10 mL is a generic medicine used for the treatment of overactive bladder and urinary incontinence. It is also used as an anti-epileptic drug to prevent seizures in patients suffering from epilepsy. 120 mg/10 mL contains papaverine hydrochloride, which acts as a local anesthetic agent when injected into the bladder. Thus, it helps in controlling urine urgency and frequency by reducing muscle contractions that cause urine flow.
Application Insights:
Based on application, the global market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. The hospital pharmacy segment dominated the market in 2017 owing to increasing usage of phethroids for various conditions such as Parkinson¢â‚¬â„¢s disease and glaucoma. Furthermore, growing awareness among patients regarding treatment at home with generic medicines is expected to boost demand over the forecast period.
The retail pharmacy segment is anticipated to witness significant growth over the forecast period owing to rising awareness about availability of a wider range of medicines in stores than those available through hospitals or clinics.
Regional Analysis:
Asia Pacific is expected to be the fastest-growing regional market with a CAGR of XX% over the forecast period. The growth can be attributed to increasing product demand in China and India, which are among the top five countries globally in terms of population. In addition, rising healthcare expenditure by governments and consumers coupled with improving infrastructure is likely to drive industry expansion over the coming years.
The U.S., on account of being one of the most developed nations across North America, has been witnessing an increase in drug consumption since past few years; this trend is projected to continue over next eight years or so due to factors such as aging population and rising prevalence of chronic diseases such as diabetes & cardiovascular disorders amongst others (Table 1).
Growth Factors:
- Increasing demand for pain relief medications
- Growing geriatric population
- Rising prevalence of chronic diseases
- Technological advancements in the field of pain management therapies
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Papaverine Hydrochloride Injection Market Research Report
By Type
30 mg/mL, 120 mg/10 mL
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Sandoz, American Regent, Jiangsu Hengrui Medicine, Chengdu Brilliant Pharmaceutical Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Papaverine Hydrochloride Injection Market Report Segments:
The global Papaverine Hydrochloride Injection market is segmented on the basis of:
Types
30 mg/mL, 120 mg/10 mL
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sandoz
- American Regent
- Jiangsu Hengrui Medicine
- Chengdu Brilliant Pharmaceutical Group
Highlights of The Papaverine Hydrochloride Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 30 mg/mL
- 120 mg/10 mL
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Papaverine Hydrochloride Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Papaverine hydrochloride injection is a medication used to treat certain types of breathing problems. It works by relaxing the muscles in the airway, which helps to improve airflow.
Some of the major companies in the papaverine hydrochloride injection market are Sandoz, American Regent, Jiangsu Hengrui Medicine, Chengdu Brilliant Pharmaceutical Group.
The papaverine hydrochloride injection market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Papaverine Hydrochloride Injection Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Papaverine Hydrochloride Injection Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Papaverine Hydrochloride Injection Market - Supply Chain
4.5. Global Papaverine Hydrochloride Injection Market Forecast
4.5.1. Papaverine Hydrochloride Injection Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Papaverine Hydrochloride Injection Market Size (000 Units) and Y-o-Y Growth
4.5.3. Papaverine Hydrochloride Injection Market Absolute $ Opportunity
5. Global Papaverine Hydrochloride Injection Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Papaverine Hydrochloride Injection Market Size and Volume Forecast by Type
5.3.1. 30 mg/mL
5.3.2. 120 mg/10 mL
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Papaverine Hydrochloride Injection Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Papaverine Hydrochloride Injection Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Papaverine Hydrochloride Injection Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Papaverine Hydrochloride Injection Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Papaverine Hydrochloride Injection Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Papaverine Hydrochloride Injection Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Papaverine Hydrochloride Injection Demand Share Forecast, 2019-2026
9. North America Papaverine Hydrochloride Injection Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Papaverine Hydrochloride Injection Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Papaverine Hydrochloride Injection Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Papaverine Hydrochloride Injection Market Size and Volume Forecast by Type
9.7.1. 30 mg/mL
9.7.2. 120 mg/10 mL
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Papaverine Hydrochloride Injection Demand Share Forecast, 2019-2026
10. Latin America Papaverine Hydrochloride Injection Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Papaverine Hydrochloride Injection Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Papaverine Hydrochloride Injection Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Papaverine Hydrochloride Injection Market Size and Volume Forecast by Type
10.7.1. 30 mg/mL
10.7.2. 120 mg/10 mL
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Papaverine Hydrochloride Injection Demand Share Forecast, 2019-2026
11. Europe Papaverine Hydrochloride Injection Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Papaverine Hydrochloride Injection Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Papaverine Hydrochloride Injection Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Papaverine Hydrochloride Injection Market Size and Volume Forecast by Type
11.7.1. 30 mg/mL
11.7.2. 20 mg/10 mL
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Papaverine Hydrochloride Injection Demand Share, 2019-2026
12. Asia Pacific Papaverine Hydrochloride Injection Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Papaverine Hydrochloride Injection Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Papaverine Hydrochloride Injection Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Papaverine Hydrochloride Injection Market Size and Volume Forecast by Type
12.7.1. 30 mg/mL
12.7.2. 120 mg/10 mL
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Papaverine Hydrochloride Injection Demand Share, 2019-2026
13. Middle East & Africa Papaverine Hydrochloride Injection Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Papaverine Hydrochloride Injection Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Papaverine Hydrochloride Injection Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Papaverine Hydrochloride Injection Market Size and Volume Forecast by Type
13.7.1. 30 mg/mL
13.7.2. 120 mg/10 mL
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Papaverine Hydrochloride Injection Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Papaverine Hydrochloride Injection Market: Market Share Analysis
14.2. Papaverine Hydrochloride Injection Distributors and Customers
14.3. Papaverine Hydrochloride Injection Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Sandoz
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. American Regent
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Jiangsu Hengrui Medicine
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Chengdu Brilliant Pharmaceutical Group
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook